Stock Market news at lse.co.uk - RSS News Feeds

Glaxosmithkline Share News (GSK)



Share News for Glaxosmithkline (GSK)


Share Price: 1,749.50Bid: 1,747.00Ask: 1,747.50Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.50Spread as %: 0.03%Open: 1,743.50High: 1,750.00Low: 1,726.50Yesterday’s Close: 1,749.50






RPT-UPDATE 3-FDA review of Glaxo/Theravance lung drug seen as positive

(Repeats to widen distribution)* FDA reviewers: Efficacy data not entirely consistent* Safety data generally consistent with other products* Analysts
[15 Apr '13]

MARKET PULSE-Sprint, Dish, Gold stocks, Life Tech, Ironwood

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News
[15 Apr '13]

MARKET PULSE-Sprint, Dish, Gold stocks, Life Tech, Ironwood

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News
[15 Apr '13]

CORRECTED-UPDATE 2-FDA reviewers give mixed views on Glaxo lung drug

(Changes headline to reflect that FDA reviewers, not advisory panel, gave opinion on drug)* FDA reviewers: efficacy data not entirely consistent* Say
[15 Apr '13]

MARKET PULSE-Sprint, Dish, Gold stocks, Life Tech, Ironwood

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News
[15 Apr '13]

CORRECTED-MARKET PULSE-MetroPCS, Life, Sprint, Citigroup, J.C. Penney

(Corrects Citigroup item to reflect the correct percentage figure)April 15 (Reuters) - Some U.S. stocks to watch on Monday:WALL ST TO OPEN LOWER AFTER
[15 Apr '13]

UPDATE 1-U.S. justices decline to hear Glaxo appeal over Avandia

By Lawrence HurleyWASHINGTON, April 15 (Reuters) - The U.S. Supreme Court on Monday declined to consider whether private insurers can sue giant drugma
[15 Apr '13]

U.S. justices decline to hear Glaxo appeal over Avandia

WASHINGTON, April 15 (Reuters) - The U.S. Supreme Court on Monday declined to consider whether private insurers can sue giant drugmaker GlaxoSmithKlin
[15 Apr '13]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.